Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | AMGN | REGN | VRTX | GILD |
| Company | Csl Ltd ADR | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 100.8650 | 320.61 | 998.00 | 498.30 | 86.79 |
| High | 101.1350 | 322.56 | 1,002.69 | 498.63 | 87.17 |
| Low | 100.8025 | 319.18 | 989.77 | 480.79 | 86.01 |
| Last | 101.1200 | 321.66 | 990.68 | 483.00 | 86.72 |
| Change | +0.4200 | +0.33 | -7.55 | -15.73 | -0.64 |
| % Change | +0.42% | +0.10% | -0.76% | -3.15% | -0.73% |
| Volume | 17,600 | 1,552,100 | 869,200 | 2,260,000 | 4,365,000 |
| 20-Day Average Volume | 18,305 | 1,906,935 | 743,170 | 1,034,765 | 5,178,465 |
| Previous Close | 100.7000 | 321.33 | 998.23 | 498.73 | 87.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 99.5395 | 322.09 | 1,023.67 | 469.40 | 84.75 |
| 20-Day Raw Stochastic | 99.64% | 35.17% | 0.55% | 68.69% | 84.02% |
| 20-Day Relative Strength | 53.06% | 47.64% | 33.24% | 53.87% | 66.79% |
| Weighted Alpha | +30.38 | +15.26 | +14.84 | +30.67 | +19.80 |
| Today's Opinion | 40% Buy | 24% Buy | 24% Sell | 56% Buy | 100% Buy |
| Previous Opinion | 40% Buy | 24% Buy | 24% Sell | 56% Buy | 100% Buy |
| Last Month's Opinion | 64% Buy | 96% Buy | 80% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.93% since 10/11/24 | -2.04% since 10/11/24 | -2.46% since 10/11/24 | +0.27% since 10/11/24 | +2.08% since 10/11/24 |
| Low | 98.2700 on 10/16/24 | 319.18 on 10/18/24 | 989.77 on 10/18/24 | 478.90 on 10/14/24 | 84.34 on 10/14/24 |
| High | 101.1350 on 10/18/24 | 327.33 on 10/15/24 | 1,024.36 on 10/15/24 | 499.09 on 10/17/24 | 87.65 on 10/17/24 |
| 1-Month | |||||
| %Chg | +1.10% since 09/18/24 | -3.38% since 09/18/24 | -13.01% since 09/18/24 | +1.86% since 09/18/24 | +3.37% since 09/18/24 |
| Low | 96.9400 on 10/11/24 | 312.16 on 09/25/24 | 989.77 on 10/18/24 | 447.70 on 10/07/24 | 81.83 on 09/26/24 |
| High | 101.1350 on 10/18/24 | 339.17 on 09/23/24 | 1,165.85 on 09/19/24 | 499.09 on 10/17/24 | 87.65 on 10/17/24 |
| 3-Month | |||||
| %Chg | -3.13% since 07/18/24 | -2.81% since 07/18/24 | -7.18% since 07/18/24 | -1.05% since 07/18/24 | +17.97% since 07/18/24 |
| Low | 95.0500 on 09/10/24 | 306.59 on 08/07/24 | 989.77 on 10/18/24 | 447.70 on 10/07/24 | 70.78 on 07/23/24 |
| High | 109.0000 on 08/28/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 87.65 on 10/17/24 |
| 6-Month | |||||
| %Chg | +16.34% since 04/18/24 | +22.42% since 04/18/24 | +10.82% since 04/18/24 | +22.75% since 04/18/24 | +31.08% since 04/18/24 |
| Low | 85.9600 on 04/22/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.25 on 04/19/24 | 62.07 on 05/31/24 |
| High | 109.0000 on 08/28/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 87.65 on 10/17/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 97,732,992 | 172,549,680 | 109,159,056 | 124,639,600 | 108,040,384 |
| Shares Outstanding, K | 966,505 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 14,800,000,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 2,642,000,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | N/A | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 0.77 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | 0.675 on 09/10/24 | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | 09/10/24 | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.28 | 25.98 | 0.00 | 18.59 |